Sun Pharmaceutical Industries has strengthened its global opiates manufacturing business with the acquisition of two Australian manufacturing facilities from GlaxoSmithKline. …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

